Trilogy Capital’s Oracle ORCL Stock Holding History
Bought
Maintained
Sold
Other funds holding ORCL
FWIA
Trilogy Capital's ORCL Position: Q2 2026 in Review
Trilogy Capital reduced its Oracle (ORCL) stake by 0.25% in Q2 2026, selling an estimated $1.81K and leaving 3,930 shares worth $576K. The position accounts for 0.02% of the portfolio, ranked #256.
Trilogy Capital first reported a position in ORCL in Q1 2018 and has held it in 13 quarters since. The position peaked at $1.01M in Q3 2025. 1,681 funds tracked by Wall St. Rank hold ORCL as of Q2 2026.
- Trilogy Capital held 3,930 shares of Oracle worth $576K as of Q2 2026.
- Trilogy Capital sold 10 Oracle shares in Q2 2026, an estimated $1.81K.
- Oracle made up 0.02% of Trilogy Capital's portfolio in Q2 2026, its #256 holding.
- Trilogy Capital first reported a position in Oracle in Q1 2018 and has held it in 13 quarters since.
- Trilogy Capital's Oracle position peaked at $1.01M in Q3 2025.
- 1,681 funds tracked by Wall St. Rank held Oracle as of Q2 2026.
Based on Trilogy Capital's 13F filing for Q2 2026, filed 6 Jul 2026.